tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SGHT Stock Latest News

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024
Press ReleasesSight Sciences to Report Second Quarter Financial Results on August 1, 2024
7d ago
SGHT
Sight Sciences price target raised to $6.50 from $5.40 at Morgan Stanley
PremiumThe Fly
Sight Sciences price target raised to $6.50 from $5.40 at Morgan Stanley
10d ago
SGHT
Sight Sciences up 11% after Piper positive on CMS reimbursement proposal
PremiumThe Fly
Sight Sciences up 11% after Piper positive on CMS reimbursement proposal
15d ago
SGHT
Piper says Sight Sciences, Paragon 28 codes rated higher in CMS proposal
PremiumThe Fly
Piper says Sight Sciences, Paragon 28 codes rated higher in CMS proposal
15d ago
FNA
CVRX
Sight Sciences price target raised to $6.50 from $6 at Citi
PremiumThe Fly
Sight Sciences price target raised to $6.50 from $6 at Citi
15d ago
SGHT
Sight Sciences Announces the Release of its First Sustainability Report
PremiumPress ReleasesSight Sciences Announces the Release of its First Sustainability Report
1M ago
SGHT
Sight Sciences publishes SAHARA RCT data demonstrating improved DED symptoms
PremiumThe Fly
Sight Sciences publishes SAHARA RCT data demonstrating improved DED symptoms
2M ago
SGHT
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
PremiumPress Releases
Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis
2M ago
SGHT
Sight Sciences announces publication of analysis from ROMEO study
PremiumThe Fly
Sight Sciences announces publication of analysis from ROMEO study
2M ago
SGHT
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
PremiumPress Releases
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
2M ago
SGHT
Sight Sciences price target raised to $6 from $5 at Piper Sandler
PremiumThe Fly
Sight Sciences price target raised to $6 from $5 at Piper Sandler
3M ago
SGHT
Sight Sciences backs FY24 revenue view $81M-$85M,consensus $82.48M
PremiumThe Fly
Sight Sciences backs FY24 revenue view $81M-$85M,consensus $82.48M
3M ago
SGHT
Sight Sciences reports Q1 EPS (33c), consensus (28c)
PremiumThe FlySight Sciences reports Q1 EPS (33c), consensus (28c)
3M ago
SGHT
Sight Sciences Enhances Transparency with Strategic Financial Moves
PremiumCompany Announcements
Sight Sciences Enhances Transparency with Strategic Financial Moves
3M ago
8K
SGHT
Sight Sciences announces $34M patent infringement verdict against Alcon
PremiumThe Fly
Sight Sciences announces $34M patent infringement verdict against Alcon
3M ago
ALC
SGHT
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
PremiumPress Releases
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
3M ago
SGHT
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
PremiumPress Releases
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
3M ago
SGHT
Sight Sciences publishes results from MIGS study in AJO
PremiumThe Fly
Sight Sciences publishes results from MIGS study in AJO
4M ago
SGHT
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
PremiumPress Releases
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
4M ago
SGHT
Sight Sciences to present GEMINI trial data at ASCRS
PremiumThe FlySight Sciences to present GEMINI trial data at ASCRS
4M ago
SGHT
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
PremiumPress Releases
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
4M ago
SGHT
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
PremiumPress Releases
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
4M ago
SGHT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >